March 02, 2015 2:20 PM ET

Company Overview of Marbrijen Pty Ltd

Executive Profile

Iain MacGregor Crawford Kirkwood MA (Hons) (Oxon), FCPA, CA, MAICD

Executive Chairman, Chairman of Audit Committee and Member of Remuneration & Nomination Committee, Avexa Ltd.
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 9 different industries.

See Board Relationships
62$121,500

Background

Mr. Iain MacGregor Crawford Kirkwood, MA(Hons)(Oxon), FCPA, CA, MAICD, is the Co-Owner of Marbrijen Pty Ltd. Mr. Kirkwood served as a Consultant of Clinuvel Pharmaceuticals Limited (formerly known as EpiTan Ltd.). He served as Chief Financial Officer, Chief Administrative Officer and Company Secretary of Clinuvel Pharmaceuticals Limited. He served as the Chief Executive Officer and Managing Director of Clinuvel Pharmaceuticals Limited from February 1, 2005 to November ...

Corporate Headquarters

--
--, -- --

Australia

Phone: --
Fax: --

Board Members Memberships

Non-Executive Director
Independent Non Executive Director
2003-2013
Former Non Executive Director and Chairman of Audit & Risk Committee
2004-Present
Non-Executive Director, Chairman of Audit & Risk Management Committee and Member of Remuneration Committee
2005-2005
Former Chief Executive Officer, Chief Administrative Officer, Chief Financial Officer and Company Secretary
2007-Present
Non-Executive Chairman and Chairman of Audit Committee
2008-2009
Former Company Secretary, Non-Executive Director and Chairman of Audit Committee
2010-Present
Executive Chairman, Chairman of Audit Committee and Member of Remuneration & Nomination Committee
2013-Present
Chairman

Education

MA
University of Oxford

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$121,500
Total Calculated Compensation$121,500
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Kenneth C. Frazier Chairman, Chief Executive Officer and President
Merck & Co. Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Marbrijen Pty Ltd, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.